- Friday 1st of October 2021
IgM Production
The process includes gene synthesis, vector construction, plasmid preparation, and transient transfection or stable cell line development. This workflow produces IgM in pentameric or hexameric forms with appropriate disulfide bonding and J-chain formation, ensuring structural integrity and functional efficacy. We also provide traditional hybridoma technology options, including human-human and hetero-hybridomas, for IgM Production
Latest News
- Friday 1st of October 2021
“BIZ 2021” Entrepreneurial Day competition
- Friday 1st of October 2021
Workshop on modern assessment and the Use of Zoom Software in Learner-Centered Classroom (Academic staff)
- Friday 19th of March 2021
“Let’s Plant Trees for a Better Environment 2021”
- Friday 19th of March 2021
Biz 2020 – UWU Entrepreneurs’ Day
- Friday 19th of March 2021
Faculty of Management signs MoU with the Sri Lanka Institute of Marketing
- Friday 19th of March 2021
0 Replies:
Leave a Reply